Roche CEO Severin Schwan on cancer immunotherapy
Roche CEO Severin Schwan talks about cancer immunotherapy, which aims to help a person’s own immune system recognise and attack cancer. For... Learn More
Drawn to Science: T-cell bispecific antibodies
Engineered antibodies can be designed to help the body’s own defence mechanisms fight diseases. At Roche Pharma Research and Early Development, we... Learn More
Cancer immunotherapy: the PD-L1 pathway
The role of the immune system is to protect the body from foreign invaders. In responding to cancer, T cells play a... Learn More
Understanding bladder cancer: the facts
Bladder cancer is one of the world’s top ten most common cancers. Approximately 165,000 deaths are attributed to the disease globally each... Learn More